U-50,488H, a selective kappa opoid receptor agonist, ameliorates memory impairments induced by muscarinic autoreceptor agonist, carbachol in mice

Neuroscience Letters

Volumn 236, Issue 1, 1997, Pages 45-48

  Hiramatsu, Masayuki ^a   Hyodo, Takane ^a   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Carbachol; Kappa opioid receptor agonist; Learning and memory; Muscarinic autoreceptor; U 50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; AUTORECEPTOR; CARBACHOL; KAPPA OPIATE RECEPTOR AGONIST; MUSCARINIC AGENT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOSE RESPONSE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; AUTORECEPTORS; AVOIDANCE LEARNING; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY DISORDERS; MICE; MUSCARINIC AGONISTS; RECEPTORS, OPIOID, KAPPA;

EID: 0031585493     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00757-X     Document Type: Article

References (26)

1. Coyle J.T., Price D.L., Delong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
2. Daniel, W.W., Applied Nonparametric Statistics, 2nd edn., The Duxbury Advanced Series in Statistics and Decision Sciences, PWS-Kent, Boston, MA, 1990, 635 p.
3. Fisone G., Wu C.F., Consolo S., Nordström Ö., Brynne N., Bartfai T., Melander T., Hökfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc. Natl. Acad. Sci. USA. 84:1987;7339-7343.
4. Gall C. Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers. J. Neurosci. 8:1988;1852-1862.
5. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
6. + channels and adenylate cyclase. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;627-632.
7. Heijna M.H., Padt M., Hogenboom F., Portoghese P.S., Mulder A.H., Schoffelmeer A.N.M. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol. 181:1990;267-278.
8. Hiller J.M., Itzhak Y., Simon E.J. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res. 406:1987;17-23.
9. Hiramatsu M., Hyodo T., Kameyama T. U-50,488H, a selective κ-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur. J. Pharmacol. 315:1996;119-125.
10. Hiramatsu M., Mori H., Murasawa H., Kameyama T. Dynorphin A (1-13) improves galanin-induced impairment of memory accompanied by blockage of reductions in acetylcholine release in rats. Br. J. Pharmacol. 118:1996;255-260.
11. Hiramatsu, M., Murasawa, H., Mori, H. and Kameyama, T., Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid agonist, Br. J. Pharmacol., (1998) in press.
12. Hiramatsu M., Sasaki M., Kameyama T. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task. Eur. J. Pharmacol. 282:1995;185-191.
13. Houser C.R., Miyashiro J.E., Swartz B.E., Walsh G.O., Rich J.R., Delgado-Escueta A.V. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 10:1990;267-282.
14. Itoh J., Ukai M., Kameyama T. Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance. Eur. J. Pharmacol. 241:1993;99-104.
15. Jiang H.-K., Owyang V., Hong J.-S., Gallagher M. Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc. Natl. Acad. Sci. USA. 86:1989;2948-2951.
16. Lapchak P.A., Araujo D.M., Collier B. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat. Neuroscience. 31:1989;313-325.
17. McGinty J.F., Henriksen S.J., Goldstein A., Terenius L., Bloom F.E. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic administration and colchicine-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 80:1983;589-593.
18. Moor E., De Boer P., Auth F., Westerink B.H.C. Characterization of muscarinic autoreceptors in the septo-hippocampal system of the rat: a microdialysis study. Eur. J. Pharmacol. 294:1995;155-161.
19. Mulder A.H., Burger D.M., Wardeh G., Hogenboon F., Frankhuyzen A.L. Pharmacological profile of various κ-agonists at κ-, μ- and δ-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br. J. Pharmacol. 102:1991;518-522.
20. Mulder A.H., Wardeh G., Hogenboon F., Frankhuyzen A.L. κ- And δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-280.
21. 2-muscarinic receptor antagonist in aged memory-impaired rats. J. Neurosci. 15:1995;1455-1462.
22. Salin P.A., Weisskopf M.G., Nicoll R.A. A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat. J. Neurosci. 15:1995;6939-6945.
23. Sen A.P., Bhattacharya S.K. Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats. Indian J. Exp. Biol. 29:1991;136-139.
24. Sharif N.A., Hughes J. Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography species differences and comparison with kappa receptors. Peptides. 10:1989;499-522.
25. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 89:1992;2046-2050.
26. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature. 362:1993;423-427.